HealthEquity price target raised to $100 from $85 at Barrington

Barrington raised the firm’s price target on HealthEquity to $100 from $85 and keeps an Outperform rating on the shares following the investor day. The firm says that with a “strong and industry-leading” health savings account business and a recovering consumer directed benefit business, combined with a higher effective yield on cash for the next several years, it expects HealthEquity’s operating and financial performance to continue to improve on a consolidated basis going forward.